Skip to main content
Erschienen in: Pediatric Nephrology 12/2019

01.10.2018 | Educational Review

Hypertensive crisis in children and adolescents

verfasst von: Tomáš Seeman, Gilad Hamdani, Mark Mitsnefes

Erschienen in: Pediatric Nephrology | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Abstract

Hypertensive crisis is a relatively rare condition in children. However, if not treated, it might be life-threatening and lead to irreversible damage of vital organs. Clinical presentation of patients with hypertensive crisis can vary from very mild (hypertensive urgency) to severe symptoms (hypertensive emergency) despite similarly high blood pressure (BP). Individualized assessment of patients presenting with high BP with emphasis on the evaluation of end-organ damage rather than on the specific BP number is a key in guiding physician’s initial management of a hypertensive crisis. The main aim of the treatment of hypertensive crisis is the prevention or treatment of life-threatening complications of hypertension-induced organ dysfunction, including neurologic, ophthalmologic, renal, and cardiac complications. While the treatment strategy must be directed toward the immediate reduction of BP to reduce the hypertensive damage to these organs, it should not be at a too fast rate to cause hypoperfusion of vital organs by an excessively rapid reduction of BP. Thus, intravenous continuous infusions rather than intravenous boluses of antihypertensive medications should be the preferable mode of initial treatment of children with hypertensive emergency.
Literatur
1.
Zurück zum Zitat National High Blood Pressure Education Program Working Group on High Blood Pressure in C, Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114(2 Suppl 4th Report):555–576 National High Blood Pressure Education Program Working Group on High Blood Pressure in C, Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114(2 Suppl 4th Report):555–576
2.
Zurück zum Zitat Flynn JT, Tullus K (2009) Severe hypertension in children and adolescents: pathophysiology and treatment. Pediatr Nephrol 24(6):1101–1112PubMed Flynn JT, Tullus K (2009) Severe hypertension in children and adolescents: pathophysiology and treatment. Pediatr Nephrol 24(6):1101–1112PubMed
3.
Zurück zum Zitat Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, de Ferranti SD, Dionne JM, Falkner B, Flinn SK, Gidding SS, Goodwin C, Leu MG, Powers ME, Rea C, Samuels J, Simasek M, Thaker VV, Urbina EM, Subcommittee on Screening and Management of High Blood Pressure in Children (2017) Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. https://doi.org/10.1542/peds.2017-1904 PubMed Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, de Ferranti SD, Dionne JM, Falkner B, Flinn SK, Gidding SS, Goodwin C, Leu MG, Powers ME, Rea C, Samuels J, Simasek M, Thaker VV, Urbina EM, Subcommittee on Screening and Management of High Blood Pressure in Children (2017) Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. https://​doi.​org/​10.​1542/​peds.​2017-1904 PubMed
4.
Zurück zum Zitat Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee (2003) Seventh report of the joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42(6):1206–1252PubMed Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee (2003) Seventh report of the joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42(6):1206–1252PubMed
5.
Zurück zum Zitat Chandar J, Zilleruelo G (2012) Hypertensive crisis in children. Pediatr Nephrol 27(5):741–751PubMed Chandar J, Zilleruelo G (2012) Hypertensive crisis in children. Pediatr Nephrol 27(5):741–751PubMed
6.
Zurück zum Zitat Lurbe E, Agabiti-Rosei E, Cruickshank JK (2016) European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens 34(10):1887–1920PubMed Lurbe E, Agabiti-Rosei E, Cruickshank JK (2016) European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens 34(10):1887–1920PubMed
7.
Zurück zum Zitat Aronson S (2014) Perioperative hypertensive emergencies. Curr Hypertens Rep 16(7):448PubMed Aronson S (2014) Perioperative hypertensive emergencies. Curr Hypertens Rep 16(7):448PubMed
8.
Zurück zum Zitat Agarwal A, Kapur G, Altinok D (2015) Childhood posterior reversible encephalopathy syndrome: magnetic resonance imaging findings with emphasis on increased leptomeningeal FLAIR signal. Neuroradiol J 28(6):638–643PubMedPubMedCentral Agarwal A, Kapur G, Altinok D (2015) Childhood posterior reversible encephalopathy syndrome: magnetic resonance imaging findings with emphasis on increased leptomeningeal FLAIR signal. Neuroradiol J 28(6):638–643PubMedPubMedCentral
9.
10.
Zurück zum Zitat McNiece KL, Poffenbarger TS, Turner JL, Franco KD, Sorof JM, Portman RJ (2007) Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr 150(6):640–644 644 e641PubMed McNiece KL, Poffenbarger TS, Turner JL, Franco KD, Sorof JM, Portman RJ (2007) Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr 150(6):640–644 644 e641PubMed
11.
Zurück zum Zitat Wu HP, Yang WC, Wu YK, Zhao LL, Chen CY, Fu YC (2012) Clinical significance of blood pressure ratios in hypertensive crisis in children. Arch Dis Child 97(3):200–205PubMed Wu HP, Yang WC, Wu YK, Zhao LL, Chen CY, Fu YC (2012) Clinical significance of blood pressure ratios in hypertensive crisis in children. Arch Dis Child 97(3):200–205PubMed
13.
Zurück zum Zitat Yang WC, Zhao LL, Chen CY, Wu YK, Chang YJ, Wu HP (2012) First-attack pediatric hypertensive crisis presenting to the pediatric emergency department. BMC Pediatr 12:200PubMedPubMedCentral Yang WC, Zhao LL, Chen CY, Wu YK, Chang YJ, Wu HP (2012) First-attack pediatric hypertensive crisis presenting to the pediatric emergency department. BMC Pediatr 12:200PubMedPubMedCentral
14.
Zurück zum Zitat Deshmukh A, Pant S, Kumar G, Murugiah K, Mehta J (2012) Seasonal variation in hypertensive emergency hospitalization. J Clin Hypertens 14(4):269–270 Deshmukh A, Pant S, Kumar G, Murugiah K, Mehta J (2012) Seasonal variation in hypertensive emergency hospitalization. J Clin Hypertens 14(4):269–270
15.
Zurück zum Zitat Wang YC, Lin YK (2014) Association between temperature and emergency room visits for cardiorespiratory diseases, metabolic syndrome-related diseases, and accidents in metropolitan Taipei. PLoS One 9(6):e99599PubMedPubMedCentral Wang YC, Lin YK (2014) Association between temperature and emergency room visits for cardiorespiratory diseases, metabolic syndrome-related diseases, and accidents in metropolitan Taipei. PLoS One 9(6):e99599PubMedPubMedCentral
16.
Zurück zum Zitat Shea S, Misra D, Ehrlich MH, Field L, Francis CK (1992) Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population. N Engl J Med 327(11):776–781PubMed Shea S, Misra D, Ehrlich MH, Field L, Francis CK (1992) Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population. N Engl J Med 327(11):776–781PubMed
17.
Zurück zum Zitat Tisdale JE, Huang MB, Borzak S (2004) Risk factors for hypertensive crisis: importance of out-patient blood pressure control. Fam Pract 21(4):420–424PubMed Tisdale JE, Huang MB, Borzak S (2004) Risk factors for hypertensive crisis: importance of out-patient blood pressure control. Fam Pract 21(4):420–424PubMed
18.
Zurück zum Zitat Gill DG, Mendes de Costa B, Cameron JS, Joseph MC, Ogg CS, Chantler C (1976) Analysis of 100 children with severe and persistent hypertension. Arch Dis Child 51(12):951–956PubMedPubMedCentral Gill DG, Mendes de Costa B, Cameron JS, Joseph MC, Ogg CS, Chantler C (1976) Analysis of 100 children with severe and persistent hypertension. Arch Dis Child 51(12):951–956PubMedPubMedCentral
20.
Zurück zum Zitat Baker MD (1986) Theophylline toxicity in children. J Pediatr 109(3):538–542PubMed Baker MD (1986) Theophylline toxicity in children. J Pediatr 109(3):538–542PubMed
21.
Zurück zum Zitat Calenda E, Richez F, Muraine M (2007) Acute hypertension due to phenylephrine eyedrops in a newborn. Can J Ophthalmol 42(3):486PubMed Calenda E, Richez F, Muraine M (2007) Acute hypertension due to phenylephrine eyedrops in a newborn. Can J Ophthalmol 42(3):486PubMed
22.
Zurück zum Zitat Su JA, Tang W, Rivero N, Bar-Cohen Y (2014) Prenatal exposure to methyldopa leading to hypertensive crisis and cardiac failure in a neonate. Pediatrics 133(5):e1392–e1395PubMed Su JA, Tang W, Rivero N, Bar-Cohen Y (2014) Prenatal exposure to methyldopa leading to hypertensive crisis and cardiac failure in a neonate. Pediatrics 133(5):e1392–e1395PubMed
23.
Zurück zum Zitat Armstrong EP, Malone DC (2003) The impact of nonsteroidal anti-inflammatory drugs on blood pressure, with an emphasis on newer agents. Clin Ther 25(1):1–18PubMed Armstrong EP, Malone DC (2003) The impact of nonsteroidal anti-inflammatory drugs on blood pressure, with an emphasis on newer agents. Clin Ther 25(1):1–18PubMed
24.
Zurück zum Zitat Brody SL, Slovis CM, Wrenn KD (1990) Cocaine-related medical problems: consecutive series of 233 patients. Am J Med 88(4):325–331PubMed Brody SL, Slovis CM, Wrenn KD (1990) Cocaine-related medical problems: consecutive series of 233 patients. Am J Med 88(4):325–331PubMed
25.
Zurück zum Zitat Drees JC, Stone JA, Wu AH (2009) Morbidity involving the hallucinogenic designer amines MDA and 2C-I. J Forensic Sci 54(6):1485–1487PubMed Drees JC, Stone JA, Wu AH (2009) Morbidity involving the hallucinogenic designer amines MDA and 2C-I. J Forensic Sci 54(6):1485–1487PubMed
26.
Zurück zum Zitat Kaul A, Sharma RK, Gupta A, Singh U (2010) Spectrum of hypertension in post transplant. J Assoc Physicians India 8:221–224 Kaul A, Sharma RK, Gupta A, Singh U (2010) Spectrum of hypertension in post transplant. J Assoc Physicians India 8:221–224
27.
Zurück zum Zitat Luke RG (1991) Pathophysiology and treatment of posttransplant hypertension. J Am Soc Nephrol 2(2 Suppl 1):S37–S44PubMed Luke RG (1991) Pathophysiology and treatment of posttransplant hypertension. J Am Soc Nephrol 2(2 Suppl 1):S37–S44PubMed
28.
Zurück zum Zitat Zarifian A, Meleg-Smith S, O’Donovan R, Tesi RJ, Batuman V (1999) Cyclosporine-associated thrombotic microangiopathy in renal allografts. Kidney Int 155(6):2457–2466 Zarifian A, Meleg-Smith S, O’Donovan R, Tesi RJ, Batuman V (1999) Cyclosporine-associated thrombotic microangiopathy in renal allografts. Kidney Int 155(6):2457–2466
29.
Zurück zum Zitat Robson M, Cote I, Abbs I, Koffman G, Goldsmith D (2003) Thrombotic micro-angiopathy with sirolimus-based immunosuppression: potentiation of calcineurin-inhibitor-induced endothelial damage? Am J Transplant 3(3):324–327PubMed Robson M, Cote I, Abbs I, Koffman G, Goldsmith D (2003) Thrombotic micro-angiopathy with sirolimus-based immunosuppression: potentiation of calcineurin-inhibitor-induced endothelial damage? Am J Transplant 3(3):324–327PubMed
30.
Zurück zum Zitat Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR, Vinh A, Weyand CM (2011) Inflammation, immunity, and hypertension. Hypertension 57(2):132–140PubMed Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR, Vinh A, Weyand CM (2011) Inflammation, immunity, and hypertension. Hypertension 57(2):132–140PubMed
31.
Zurück zum Zitat Singh D, Akingbola O, Yosypiv I, El-Dahr S (2012) Emergency management of hypertension in children. Int J Nephrol 2012:420247PubMedPubMedCentral Singh D, Akingbola O, Yosypiv I, El-Dahr S (2012) Emergency management of hypertension in children. Int J Nephrol 2012:420247PubMedPubMedCentral
32.
Zurück zum Zitat Fleming S (2000) Malignant hypertension—the role of the paracrine renin-angiotensin system. J Pathol 192(2):135–139PubMed Fleming S (2000) Malignant hypertension—the role of the paracrine renin-angiotensin system. J Pathol 192(2):135–139PubMed
33.
Zurück zum Zitat Karabacak M, Dogan A, Turkdogan AK, Kapci M, Duman A, Akpinar O (2014) Mean platelet volume is increased in patients with hypertensive crises. Platelets 25(6):423–426PubMed Karabacak M, Dogan A, Turkdogan AK, Kapci M, Duman A, Akpinar O (2014) Mean platelet volume is increased in patients with hypertensive crises. Platelets 25(6):423–426PubMed
34.
Zurück zum Zitat Zhang B, Xing C, Yu X, Sun B, Zhao X, Qian J (2008) Renal thrombotic microangiopathies induced by severe hypertension. Hypertens Res 31(3):479–483PubMed Zhang B, Xing C, Yu X, Sun B, Zhao X, Qian J (2008) Renal thrombotic microangiopathies induced by severe hypertension. Hypertens Res 31(3):479–483PubMed
35.
Zurück zum Zitat Kitiyakara C, Guzman NJ (1998) Malignant hypertension and hypertensive emergencies. J Am Soc Nephrol 9(1):133–142PubMed Kitiyakara C, Guzman NJ (1998) Malignant hypertension and hypertensive emergencies. J Am Soc Nephrol 9(1):133–142PubMed
36.
37.
Zurück zum Zitat Vaughan CJ, Delanty N (2000) Hypertensive emergencies. Lancet 356(9227):411–417PubMed Vaughan CJ, Delanty N (2000) Hypertensive emergencies. Lancet 356(9227):411–417PubMed
38.
Zurück zum Zitat Blumenfeld JD, Laragh JH (2001) Management of hypertensive crises: the scientific basis for treatment decisions. Am J Hypertens 14(11 Pt 1):1154–1167PubMed Blumenfeld JD, Laragh JH (2001) Management of hypertensive crises: the scientific basis for treatment decisions. Am J Hypertens 14(11 Pt 1):1154–1167PubMed
39.
Zurück zum Zitat Funakoshi Y, Ichiki T, Ito K, Takeshita A (1999) Induction of interleukin-6 expression by angiotensin II in rat vascular smooth muscle cells. Hypertension 34(1):118–125PubMed Funakoshi Y, Ichiki T, Ito K, Takeshita A (1999) Induction of interleukin-6 expression by angiotensin II in rat vascular smooth muscle cells. Hypertension 34(1):118–125PubMed
40.
Zurück zum Zitat Han Y, Runge MS, Brasier AR (1999) Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors. Circ Res 84(6):695–703PubMed Han Y, Runge MS, Brasier AR (1999) Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors. Circ Res 84(6):695–703PubMed
41.
Zurück zum Zitat Ruiz-Ortega M, Lorenzo O, Ruperez M, Konig S, Wittig B, Egido J (2000) Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms. Circ Res 6(12):1266–1272 Ruiz-Ortega M, Lorenzo O, Ruperez M, Konig S, Wittig B, Egido J (2000) Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms. Circ Res 6(12):1266–1272
42.
Zurück zum Zitat Collidge TA, Lammie GA, Fleming S, Mullins JJ (2004) The role of the renin-angiotensin system in malignant vascular injury affecting the systemic and cerebral circulations. Prog Biophys Mol Biol 84(2–3):301–319PubMed Collidge TA, Lammie GA, Fleming S, Mullins JJ (2004) The role of the renin-angiotensin system in malignant vascular injury affecting the systemic and cerebral circulations. Prog Biophys Mol Biol 84(2–3):301–319PubMed
43.
Zurück zum Zitat Nakayama I, Kawahara Y, Tsuda T, Okuda M, Yokoyama M (1994) Angiotensin II inhibits cytokine-stimulated inducible nitric oxide synthase expression in vascular smooth muscle cells. J Biol Chem 269(15):11628–11633PubMed Nakayama I, Kawahara Y, Tsuda T, Okuda M, Yokoyama M (1994) Angiotensin II inhibits cytokine-stimulated inducible nitric oxide synthase expression in vascular smooth muscle cells. J Biol Chem 269(15):11628–11633PubMed
44.
Zurück zum Zitat Lee MA, Bohm M, Kim S, Bachmann S, Bachmann J, Bader M, Ganten D (1995) Differential gene expression of renin and angiotensinogen in the TGR(mREN-2)27 transgenic rat. Hypertension 25(4 Pt 1):570–580PubMed Lee MA, Bohm M, Kim S, Bachmann S, Bachmann J, Bader M, Ganten D (1995) Differential gene expression of renin and angiotensinogen in the TGR(mREN-2)27 transgenic rat. Hypertension 25(4 Pt 1):570–580PubMed
45.
Zurück zum Zitat Montgomery HE, Kiernan LA, Whitworth CE, Fleming S, Unger T, Gohlke P, Mullins JJ, McEwan JR (1998) Inhibition of tissue angiotensin converting enzyme activity prevents malignant hypertension in TGR(mREN2)27. J Hypertens 16(5):635–643PubMed Montgomery HE, Kiernan LA, Whitworth CE, Fleming S, Unger T, Gohlke P, Mullins JJ, McEwan JR (1998) Inhibition of tissue angiotensin converting enzyme activity prevents malignant hypertension in TGR(mREN2)27. J Hypertens 16(5):635–643PubMed
46.
Zurück zum Zitat Muller DN, Dechend R, Mervaala EM, Park JK, Schmidt F, Fiebeler A, Theuer J (2000) NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension 35(1 Pt 2):193–201PubMed Muller DN, Dechend R, Mervaala EM, Park JK, Schmidt F, Fiebeler A, Theuer J (2000) NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension 35(1 Pt 2):193–201PubMed
47.
Zurück zum Zitat Mazak I, Fiebeler A, Muller DN, Park JK, Shagdarsuren E, Lindschau C, Dechend R, Viedt C, Pilz B, Haller H, Luft FC (2004) Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells. Circulation 109(22):2792–2800PubMed Mazak I, Fiebeler A, Muller DN, Park JK, Shagdarsuren E, Lindschau C, Dechend R, Viedt C, Pilz B, Haller H, Luft FC (2004) Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells. Circulation 109(22):2792–2800PubMed
48.
Zurück zum Zitat Lassegue B, Griendling KK (2004) Reactive oxygen species in hypertension; an update. Am J Hypertens 17(9):852–860PubMed Lassegue B, Griendling KK (2004) Reactive oxygen species in hypertension; an update. Am J Hypertens 17(9):852–860PubMed
49.
Zurück zum Zitat Touyz RM (2004) Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44(3):248–252PubMed Touyz RM (2004) Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44(3):248–252PubMed
50.
Zurück zum Zitat Park JB, Touyz RM, Chen X, Schiffrin EL (2002) Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats. Am J Hypertens 15(1 Pt 1):78–84PubMed Park JB, Touyz RM, Chen X, Schiffrin EL (2002) Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats. Am J Hypertens 15(1 Pt 1):78–84PubMed
51.
Zurück zum Zitat Lip GY, Edmunds E, Nuttall SL, Landray MJ, Blann AD, Beevers DG (2002) Oxidative stress in malignant and non-malignant phase hypertension. J Hum Hypertens 16(5):333–336PubMed Lip GY, Edmunds E, Nuttall SL, Landray MJ, Blann AD, Beevers DG (2002) Oxidative stress in malignant and non-malignant phase hypertension. J Hum Hypertens 16(5):333–336PubMed
52.
Zurück zum Zitat Endemann DH, Schiffrin EL (2004) Endothelial dysfunction. J Am Soc Nephrol 15(8):1983–1992PubMed Endemann DH, Schiffrin EL (2004) Endothelial dysfunction. J Am Soc Nephrol 15(8):1983–1992PubMed
53.
Zurück zum Zitat Sato K, Kinoshita M, Kojima M, Miyagawa K, Takase H, Suzuki S, Dohi Y (2000) Failure of L-arginine to induce hypotension in patients with a history of accelerated-malignant hypertension. J Hum Hypertens 14(8):485–488PubMed Sato K, Kinoshita M, Kojima M, Miyagawa K, Takase H, Suzuki S, Dohi Y (2000) Failure of L-arginine to induce hypotension in patients with a history of accelerated-malignant hypertension. J Hum Hypertens 14(8):485–488PubMed
54.
Zurück zum Zitat Lip GY, Edmunds E, Hee FL, Blann AD, Beevers DG (2001) A cross-sectional, diurnal, and follow-up study of platelet activation and endothelial dysfunction in malignant phase hypertension. Am J Hypertens 14(8 Pt 1):823–828PubMed Lip GY, Edmunds E, Hee FL, Blann AD, Beevers DG (2001) A cross-sectional, diurnal, and follow-up study of platelet activation and endothelial dysfunction in malignant phase hypertension. Am J Hypertens 14(8 Pt 1):823–828PubMed
55.
Zurück zum Zitat Schwartz RB, Feske SK, Polak JF, DeGirolami U, Iaia A, Beckner KM, Bravo SM, Klufas RA, Chai RY, Repke JT (2000) Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology 217(2):371–376PubMed Schwartz RB, Feske SK, Polak JF, DeGirolami U, Iaia A, Beckner KM, Bravo SM, Klufas RA, Chai RY, Repke JT (2000) Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology 217(2):371–376PubMed
56.
Zurück zum Zitat Derhaschnig U, Testori C, Riedmueller E, Aschauer S, Wolzt M, Jilma B (2013) Hypertensive emergencies are associated with elevated markers of inflammation, coagulation, platelet activation and fibrinolysis. J Hum Hypertens 27(6):368–373PubMed Derhaschnig U, Testori C, Riedmueller E, Aschauer S, Wolzt M, Jilma B (2013) Hypertensive emergencies are associated with elevated markers of inflammation, coagulation, platelet activation and fibrinolysis. J Hum Hypertens 27(6):368–373PubMed
57.
Zurück zum Zitat Al Bannay R, Bohm M, Husain A (2013) Heart rate differentiates urgency and emergency in hypertensive crisis. Clin Res Cardiol 102(8):593–598PubMed Al Bannay R, Bohm M, Husain A (2013) Heart rate differentiates urgency and emergency in hypertensive crisis. Clin Res Cardiol 102(8):593–598PubMed
58.
Zurück zum Zitat Karabacak M, Yigit M, Turkdogan KA, Yigit E, Selek S (2015) Is signal peptide-CUB-EGF domain-containing protein1 a diagnostic biomarker in patients with hypertensive crises. Clin Hemorheol Microcirc 61(3):513–522PubMed Karabacak M, Yigit M, Turkdogan KA, Yigit E, Selek S (2015) Is signal peptide-CUB-EGF domain-containing protein1 a diagnostic biomarker in patients with hypertensive crises. Clin Hemorheol Microcirc 61(3):513–522PubMed
59.
Zurück zum Zitat Jorg R, Milani GP, Simonetti GD, Bianchetti MG, Simonetti BG (2013) Peripheral facial nerve palsy in severe systemic hypertension: a systematic review. Am J Hypertens 26(3):351–356PubMed Jorg R, Milani GP, Simonetti GD, Bianchetti MG, Simonetti BG (2013) Peripheral facial nerve palsy in severe systemic hypertension: a systematic review. Am J Hypertens 26(3):351–356PubMed
60.
Zurück zum Zitat Ahn CH, Han SA, Kong YH, Kim SJ (2017) Clinical characteristics of hypertensive encephalopathy in pediatric patients. Korean J Pediatr 60(8):266–271PubMedPubMedCentral Ahn CH, Han SA, Kong YH, Kim SJ (2017) Clinical characteristics of hypertensive encephalopathy in pediatric patients. Korean J Pediatr 60(8):266–271PubMedPubMedCentral
61.
Zurück zum Zitat Kwon S, Koo J, Lee S (2001) Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol 24(5):361–364PubMed Kwon S, Koo J, Lee S (2001) Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol 24(5):361–364PubMed
62.
Zurück zum Zitat Stevens CJ, Heran MK (2012) The many faces of posterior reversible encephalopathy syndrome. Br J Radiol 85(1020):1566–1575PubMedPubMedCentral Stevens CJ, Heran MK (2012) The many faces of posterior reversible encephalopathy syndrome. Br J Radiol 85(1020):1566–1575PubMedPubMedCentral
63.
Zurück zum Zitat Lee VH, Wijdicks EF, Manno EM, Rabinstein AA (2008) Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 65(2):205–210PubMed Lee VH, Wijdicks EF, Manno EM, Rabinstein AA (2008) Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 65(2):205–210PubMed
64.
Zurück zum Zitat Onder AM, Lopez R, Teomete U, Francoeur D, Bhatia R, Knowbi O, Hizaji R, Chandar J, Abitbol C, Zilleruelo G (2007) Posterior reversible encephalopathy syndrome in the pediatric renal population. Pediatr Nephrol 22(11):1921–1929PubMed Onder AM, Lopez R, Teomete U, Francoeur D, Bhatia R, Knowbi O, Hizaji R, Chandar J, Abitbol C, Zilleruelo G (2007) Posterior reversible encephalopathy syndrome in the pediatric renal population. Pediatr Nephrol 22(11):1921–1929PubMed
65.
Zurück zum Zitat Gera DN, Patil SB, Iyer A, Kute VB, Gandhi S, Kumar D, Trivedi HL (2014) Posterior reversible encephalopathy syndrome in children with kidney disease. Indian J Nephrol 24(1):28–34PubMedPubMedCentral Gera DN, Patil SB, Iyer A, Kute VB, Gandhi S, Kumar D, Trivedi HL (2014) Posterior reversible encephalopathy syndrome in children with kidney disease. Indian J Nephrol 24(1):28–34PubMedPubMedCentral
66.
Zurück zum Zitat Gardner CJ, Lee K (2007) Hyperperfusion syndromes: insight into the pathophysiology and treatment of hypertensive encephalopathy. CNS Spectr 12(1):35–42PubMed Gardner CJ, Lee K (2007) Hyperperfusion syndromes: insight into the pathophysiology and treatment of hypertensive encephalopathy. CNS Spectr 12(1):35–42PubMed
67.
Zurück zum Zitat Kahana A, Rowley HA, Weinstein JM (2005) Cortical blindness: clinical and radiologic findings in reversible posterior leukoencephalopathy syndrome: case report and review of the literature. Ophthalmology 112(2):e7–e11PubMed Kahana A, Rowley HA, Weinstein JM (2005) Cortical blindness: clinical and radiologic findings in reversible posterior leukoencephalopathy syndrome: case report and review of the literature. Ophthalmology 112(2):e7–e11PubMed
68.
Zurück zum Zitat Kandt RS, Caoili AQ, Lorentz WB, Elster AD (1995) Hypertensive encephalopathy in children: neuroimaging and treatment. J Child Neurol 10(3):236–239PubMed Kandt RS, Caoili AQ, Lorentz WB, Elster AD (1995) Hypertensive encephalopathy in children: neuroimaging and treatment. J Child Neurol 10(3):236–239PubMed
69.
Zurück zum Zitat Lin KL, Hsu WC, Wang HS, Lui TN (2006) Hypertension-induced cerebellar encephalopathy and hydrocephalus in a male. Pediatr Neurol 34(1):72–75PubMed Lin KL, Hsu WC, Wang HS, Lui TN (2006) Hypertension-induced cerebellar encephalopathy and hydrocephalus in a male. Pediatr Neurol 34(1):72–75PubMed
70.
Zurück zum Zitat Sanford EF, Stein JC (2012) Hypertensive encephalopathy presenting as status epilepticus in a three year old. J Emerg Med 42(6):e141–e145PubMed Sanford EF, Stein JC (2012) Hypertensive encephalopathy presenting as status epilepticus in a three year old. J Emerg Med 42(6):e141–e145PubMed
71.
Zurück zum Zitat Logan P, Eustace P, Robinson R (1992) Hypertensive retinopathy: a cause of decreased visual acuity in children. J Pediatr Ophthalmol Strabismus 29(5):287–289PubMed Logan P, Eustace P, Robinson R (1992) Hypertensive retinopathy: a cause of decreased visual acuity in children. J Pediatr Ophthalmol Strabismus 29(5):287–289PubMed
72.
Zurück zum Zitat Henderson AD, Biousse V, Newman NJ, Lamirel C, Wright DW, Bruce BB (2012) Grade III or grade IV hypertensive retinopathy with severely elevated blood pressure. West J Emerg Med 13(6):529–534PubMedPubMedCentral Henderson AD, Biousse V, Newman NJ, Lamirel C, Wright DW, Bruce BB (2012) Grade III or grade IV hypertensive retinopathy with severely elevated blood pressure. West J Emerg Med 13(6):529–534PubMedPubMedCentral
73.
Zurück zum Zitat Williams KM, Shah AN, Morrison D, Sinha MD (2013) Hypertensive retinopathy in severely hypertensive children: demographic, clinical, and ophthalmoscopic findings from a 30-year British cohort. J Pediatr Ophthalmol Strabismus 50(4):222–228PubMed Williams KM, Shah AN, Morrison D, Sinha MD (2013) Hypertensive retinopathy in severely hypertensive children: demographic, clinical, and ophthalmoscopic findings from a 30-year British cohort. J Pediatr Ophthalmol Strabismus 50(4):222–228PubMed
74.
Zurück zum Zitat Kovalski Y, Cleper R, Krause I, Dekel B, Belenky A, Davidovits M (2012) Hyponatremic hypertensive syndrome in pediatric patients: is it really so rare? Pediatr Nephrol 27(6):1037–1040PubMed Kovalski Y, Cleper R, Krause I, Dekel B, Belenky A, Davidovits M (2012) Hyponatremic hypertensive syndrome in pediatric patients: is it really so rare? Pediatr Nephrol 27(6):1037–1040PubMed
75.
Zurück zum Zitat Mukherjee D, Sinha R, Akhtar MS, Saha AS (2017) Hyponatremic hypertensive syndrome—a retrospective cohort study. World J Nephrol 6(1):41–44PubMedPubMedCentral Mukherjee D, Sinha R, Akhtar MS, Saha AS (2017) Hyponatremic hypertensive syndrome—a retrospective cohort study. World J Nephrol 6(1):41–44PubMedPubMedCentral
76.
Zurück zum Zitat Dionne JM, Flynn JT (2017) Management of severe hypertension in the newborn. Arch Dis Child 102(12):1176–1179PubMed Dionne JM, Flynn JT (2017) Management of severe hypertension in the newborn. Arch Dis Child 102(12):1176–1179PubMed
77.
Zurück zum Zitat Adelman RD (1978) Neonatal hypertension. Pediatr Clin N Am 25(1):99–110 Adelman RD (1978) Neonatal hypertension. Pediatr Clin N Am 25(1):99–110
78.
Zurück zum Zitat Kovacikova L, Kunovsky P, Skrak P, Haviar D, Martanovic P (2005) Renovascular hypertension in infant presenting with cardiogenic shock. Pediatr Emerg Care 21(5):322–324PubMed Kovacikova L, Kunovsky P, Skrak P, Haviar D, Martanovic P (2005) Renovascular hypertension in infant presenting with cardiogenic shock. Pediatr Emerg Care 21(5):322–324PubMed
79.
Zurück zum Zitat Xiao N, Tandon A, Goldstein S, Lorts A (2013) Cardiogenic shock as the initial presentation of neonatal systemic hypertension. J Neonatal-Perinatal Med 6(3):267–272PubMed Xiao N, Tandon A, Goldstein S, Lorts A (2013) Cardiogenic shock as the initial presentation of neonatal systemic hypertension. J Neonatal-Perinatal Med 6(3):267–272PubMed
80.
Zurück zum Zitat Belsh CW (2013) Management of hypertensive emergencies. In: Flynn JT, Ingelfinger JR, Portman RJ (eds) Pediatric hypertension. Humana Press, New York, pp 557–571 Belsh CW (2013) Management of hypertensive emergencies. In: Flynn JT, Ingelfinger JR, Portman RJ (eds) Pediatric hypertension. Humana Press, New York, pp 557–571
81.
Zurück zum Zitat Adelman RD, Coppo R, Dillon MJ (2000) The emergency management of severe hypertension. Pediatr Nephrol 14:422–427PubMed Adelman RD, Coppo R, Dillon MJ (2000) The emergency management of severe hypertension. Pediatr Nephrol 14:422–427PubMed
82.
Zurück zum Zitat Patel HR, Mitsnefes MM (2005) Advances in the pathogenesis and management of hypertensive crisis. Curr Opin Pediatr 17:210–214PubMed Patel HR, Mitsnefes MM (2005) Advances in the pathogenesis and management of hypertensive crisis. Curr Opin Pediatr 17:210–214PubMed
83.
Zurück zum Zitat Vaughan CJ, Delanty N (2001) Hypertensive emergencies. Lancet 56:411–417 Vaughan CJ, Delanty N (2001) Hypertensive emergencies. Lancet 56:411–417
84.
Zurück zum Zitat Gordillo-Paniagua G, Velásquez-Jones L, Martini R, Valdez-Bolaños E (1975) Sodium nitroprusside treatment of severe arterial hypertension in children. J Pediatr 87:799–802PubMed Gordillo-Paniagua G, Velásquez-Jones L, Martini R, Valdez-Bolaños E (1975) Sodium nitroprusside treatment of severe arterial hypertension in children. J Pediatr 87:799–802PubMed
85.
Zurück zum Zitat Webb TN, Shatat IF, Miyashita Y (2014) Therapy of acute hypertension in hospitalized children and adolescents. Curr Hypertens Rep 16:425PubMedPubMedCentral Webb TN, Shatat IF, Miyashita Y (2014) Therapy of acute hypertension in hospitalized children and adolescents. Curr Hypertens Rep 16:425PubMedPubMedCentral
86.
Zurück zum Zitat McCrory WW, Kohaut EC, Lewy JE, Lieberman E, Travis LB (1979) Safety of intravenous diazoxide in children with severe hypertension. Clin Pediatr 18:661–663 666–667, 671 McCrory WW, Kohaut EC, Lewy JE, Lieberman E, Travis LB (1979) Safety of intravenous diazoxide in children with severe hypertension. Clin Pediatr 18:661–663 666–667, 671
87.
Zurück zum Zitat Rodriguez MA, Kumar SK, De Caro M (2010) Hypertensive crisis. Cardiol Rev 18:102–107PubMed Rodriguez MA, Kumar SK, De Caro M (2010) Hypertensive crisis. Cardiol Rev 18:102–107PubMed
88.
Zurück zum Zitat Flynn JT, Mottes TA, Brophy PD, Kershaw DB, Smoyer WE, Bunchman TE (2001) Intravenous nicardipine for treatment of severe hypertension in children. J Pediatr 139:38–43PubMed Flynn JT, Mottes TA, Brophy PD, Kershaw DB, Smoyer WE, Bunchman TE (2001) Intravenous nicardipine for treatment of severe hypertension in children. J Pediatr 139:38–43PubMed
89.
Zurück zum Zitat Michael J, Groshong T, Tobias JD (1998) Nicardipine for hypertensive emergencies in children with renal disease. Pediatr Nephrol 12:40–42PubMed Michael J, Groshong T, Tobias JD (1998) Nicardipine for hypertensive emergencies in children with renal disease. Pediatr Nephrol 12:40–42PubMed
90.
Zurück zum Zitat Thomas CA, Moffett BS, Wagner JL, Mott AR, Feig DI (2001) Safety and efficacy of intravenous labetalol for hypertensive crisis in infants and small children. Pediatr Crit Care Med 12:28–32 Thomas CA, Moffett BS, Wagner JL, Mott AR, Feig DI (2001) Safety and efficacy of intravenous labetalol for hypertensive crisis in infants and small children. Pediatr Crit Care Med 12:28–32
91.
Zurück zum Zitat Schöber JG, Pilossoff W, Bühlmeyer K (1984) Urapidil therapy for acute hypertensive crises in infants and children. Eur J Pediatr 143:87–91PubMed Schöber JG, Pilossoff W, Bühlmeyer K (1984) Urapidil therapy for acute hypertensive crises in infants and children. Eur J Pediatr 143:87–91PubMed
92.
Zurück zum Zitat Pio L, Avanzini S, Mattioli G, Martucciello G, Sementa AR, Conte M, Gigliotti A, Granata C, Leva E, Fagnani AM, Caccioppoli U, Tedesco N, Schleef J, Tirtei E, Siracusa F, D'Angelo P, Lelli Chiesa P, Miglionico L, Noccioli B, Severi E, Carlini C, Vaccarella F, Camoglio F, Cesaro S, Narciso A, Riccipetitoni G, Cecchetto G, Inserra A (2017) Perioperative management of hypertensive neuroblastoma: a study from the Italian Group of Pediatric Surgical Oncologists (GICOP). J Pediatr Surg 52:1633–1636PubMed Pio L, Avanzini S, Mattioli G, Martucciello G, Sementa AR, Conte M, Gigliotti A, Granata C, Leva E, Fagnani AM, Caccioppoli U, Tedesco N, Schleef J, Tirtei E, Siracusa F, D'Angelo P, Lelli Chiesa P, Miglionico L, Noccioli B, Severi E, Carlini C, Vaccarella F, Camoglio F, Cesaro S, Narciso A, Riccipetitoni G, Cecchetto G, Inserra A (2017) Perioperative management of hypertensive neuroblastoma: a study from the Italian Group of Pediatric Surgical Oncologists (GICOP). J Pediatr Surg 52:1633–1636PubMed
93.
Zurück zum Zitat Tabbutt S, Nicolson SC, Adamson PC, Zhang X, Hoffman ML, Wells W, Backer CL, McGowan FX, Tweddell JS, Bokesch P, Schreiner M (2008) The safety, efficacy, and pharmacokinetics of esmolol for blood pressure control immediately after repair of coarctation of the aorta in infants and children: a multicenter, double-blind, randomized trial. J Thorac Cardiovasc Surg 136:321–328PubMed Tabbutt S, Nicolson SC, Adamson PC, Zhang X, Hoffman ML, Wells W, Backer CL, McGowan FX, Tweddell JS, Bokesch P, Schreiner M (2008) The safety, efficacy, and pharmacokinetics of esmolol for blood pressure control immediately after repair of coarctation of the aorta in infants and children: a multicenter, double-blind, randomized trial. J Thorac Cardiovasc Surg 136:321–328PubMed
94.
Zurück zum Zitat Sica DA (2007) Centrally acting antihypertensive agents: an update. J Clin Hypertens 9:399–405 Sica DA (2007) Centrally acting antihypertensive agents: an update. J Clin Hypertens 9:399–405
95.
Zurück zum Zitat Hammer GB, Verghese ST, Drover DR, Yaster M, Tobin JR (2008) pharmacokinetics and pharmacodynamics of fenoldopam mesylate for blood pressure control in pediatric patients. BMC Anesthesiol 8:6PubMedPubMedCentral Hammer GB, Verghese ST, Drover DR, Yaster M, Tobin JR (2008) pharmacokinetics and pharmacodynamics of fenoldopam mesylate for blood pressure control in pediatric patients. BMC Anesthesiol 8:6PubMedPubMedCentral
96.
Zurück zum Zitat Wells TG, Bunchman TE, Kearns GL (1990) Treatment of neonatal hypertension with enalaprilat. J Pediatr 117:664–667PubMed Wells TG, Bunchman TE, Kearns GL (1990) Treatment of neonatal hypertension with enalaprilat. J Pediatr 117:664–667PubMed
97.
Zurück zum Zitat Rouine-Rapp K, Mello DM, Hanley FL, Mohan Reddy V, Soifer S (2003) Effect of enalaprilat on postoperative hypertension after surgical repair of coarctation of the aorta. Pediatr Crit Care Med 4:327–332PubMed Rouine-Rapp K, Mello DM, Hanley FL, Mohan Reddy V, Soifer S (2003) Effect of enalaprilat on postoperative hypertension after surgical repair of coarctation of the aorta. Pediatr Crit Care Med 4:327–332PubMed
98.
Zurück zum Zitat Blaszak RT, Savage JA, Ellis EN (2001) The use of short-acting nifedipine in pediatric patients with hypertension. J Pediatr 139:34–37PubMed Blaszak RT, Savage JA, Ellis EN (2001) The use of short-acting nifedipine in pediatric patients with hypertension. J Pediatr 139:34–37PubMed
99.
Zurück zum Zitat Miyashita Y, Peterson D, Rees JM, Flynn JT (2010) Isradipine for treatment of acute hypertension in hospitalized children and adolescents. J Clin Hypertens 12:850–855 Miyashita Y, Peterson D, Rees JM, Flynn JT (2010) Isradipine for treatment of acute hypertension in hospitalized children and adolescents. J Clin Hypertens 12:850–855
100.
Zurück zum Zitat Sinaiko AR, Kashtan CE, Mirkin BL (1986) Antihypertensive drug therapy with captopril in children and adolescents. Clin Exp Hypertens 8:829–839 Sinaiko AR, Kashtan CE, Mirkin BL (1986) Antihypertensive drug therapy with captopril in children and adolescents. Clin Exp Hypertens 8:829–839
101.
Zurück zum Zitat Joynt KE, Moslehi JJ, Baughman KL (2009) Paragangliomas: etiology, presentation, and management. Cardiol Rev 17:159–164PubMed Joynt KE, Moslehi JJ, Baughman KL (2009) Paragangliomas: etiology, presentation, and management. Cardiol Rev 17:159–164PubMed
102.
Zurück zum Zitat Pennisi AJ, Takahashi M, Bernstein BH, Singsen BH, Uittenbogaart C, Ettenger RB, Malekzadeh MH, Hanson V, Fine RN (1977) Minoxidil therapy in children with severe hypertension. J Pediatr 90:813–819PubMed Pennisi AJ, Takahashi M, Bernstein BH, Singsen BH, Uittenbogaart C, Ettenger RB, Malekzadeh MH, Hanson V, Fine RN (1977) Minoxidil therapy in children with severe hypertension. J Pediatr 90:813–819PubMed
103.
Zurück zum Zitat Strife CF, Quinlan M, Waldo FB, Fryer CJ, Jackson EC, Welch TR, McEnery PT, West CD (1986) Minoxidil for control of acute blood pressure elevation in chronically hypertensive children. Pediatrics 78:861–865PubMed Strife CF, Quinlan M, Waldo FB, Fryer CJ, Jackson EC, Welch TR, McEnery PT, West CD (1986) Minoxidil for control of acute blood pressure elevation in chronically hypertensive children. Pediatrics 78:861–865PubMed
104.
Zurück zum Zitat Wiest DB, Garner SS, Uber WE, Sade RM (1998) Esmolol for the management of pediatric hypertension after cardiac operations. J Thorac Cardiovasc Surg 115:890–897PubMed Wiest DB, Garner SS, Uber WE, Sade RM (1998) Esmolol for the management of pediatric hypertension after cardiac operations. J Thorac Cardiovasc Surg 115:890–897PubMed
105.
Zurück zum Zitat Ku LC, Zimmerman K, Benjamin DK, Clark RH, Hornik CP, Smith PB, Best Pharmaceuticals for Children Act – Pediatric Trials Network Steering Committee (2017) Safety of enalapril in infants admitted to the neonatal intensive care unit. Pediatr Cardiol 38:155–161PubMed Ku LC, Zimmerman K, Benjamin DK, Clark RH, Hornik CP, Smith PB, Best Pharmaceuticals for Children Act – Pediatric Trials Network Steering Committee (2017) Safety of enalapril in infants admitted to the neonatal intensive care unit. Pediatr Cardiol 38:155–161PubMed
106.
Zurück zum Zitat Saland JM, Mahony L, Baum M (2001) Perinatal renal ischemia resulting in hypertensive cardiomyopathy. Pediatrics 107:185–186PubMed Saland JM, Mahony L, Baum M (2001) Perinatal renal ischemia resulting in hypertensive cardiomyopathy. Pediatrics 107:185–186PubMed
107.
Zurück zum Zitat Plumer LB, Kaplan GW, Mendoza SA (1976) Hypertension in infants—a complication of umbilical arterial catheterization. J Pediatr 89:802–805PubMed Plumer LB, Kaplan GW, Mendoza SA (1976) Hypertension in infants—a complication of umbilical arterial catheterization. J Pediatr 89:802–805PubMed
108.
Zurück zum Zitat Ljungqvist A, Wallgren G (1962) Unilateral renal artery stenosis and fatal arterial hypertension in a newborn infant. Acta Paediatr 51:575–584PubMed Ljungqvist A, Wallgren G (1962) Unilateral renal artery stenosis and fatal arterial hypertension in a newborn infant. Acta Paediatr 51:575–584PubMed
Metadaten
Titel
Hypertensive crisis in children and adolescents
verfasst von
Tomáš Seeman
Gilad Hamdani
Mark Mitsnefes
Publikationsdatum
01.10.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 12/2019
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-018-4092-2

Weitere Artikel der Ausgabe 12/2019

Pediatric Nephrology 12/2019 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.